SCHEMBL16616583

SCHEMBL16616583

CC(=O)OC(C)OC(C)O[SiH3]

nearest known ligand 0.46

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
GALR3 O60755 1/20 0.34
MAPT P10636 1/20 0.34
BLM P54132 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1460735 0.87 TSHR (0.58) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL3751956 0.80 TSHR (0.50) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL17489303 0.80 TSHR (0.50) TSHRCHRM2CHRM4CHRM1TBXA2R
Alcohol SCHEMBL28868345 0.79 TSHR (0.44) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL14365840 0.78 TSHR (0.48) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL3035233 0.77 TSHR (0.60) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL23529412 0.77 TSHR (0.38) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL987906 0.76 TSHR (0.65) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL15841372 0.76 TSHR (0.37) TSHR
SCHEMBL8420800 0.75 TSHR (0.50) TSHRCHRM2CHRM4CHRM1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260118791-A1 TONER CANON KK (JP) 2026-04-30 US disclosed
EP-4086705-B1 TONER CANON KK (JP) 2026-03-25 EP disclosed
EP-4012501-B1 EXTERNAL ADDITIVE FOR TONER, TONER AND IMAGE FORMING APPARATUS CANON KK (JP) 2026-02-11 EP disclosed
EP-3654105-B1 PROCESS CARTRIDGE AND IMAGE FORMING APPARATUS CANON KK (JP) 2026-01-28 EP disclosed
US-12487539-B2 Fine particle, external additive for toners, and toner CANON KABUSHIKI KAISHA (JP) 2025-12-02 US disclosed
US-20250355380-A1 TWO-COMPONENT DEVELOPER CANON KK (JP) 2025-11-20 US disclosed
US-20250334892-A1 FINE POWDER FOR TONER AND TONER CANON KK (JP) 2025-10-30 US disclosed
US-20250334896-A1 EXTERNAL ADDITIVE FOR TONER AND TONER CANON KK (JP) 2025-10-30 US disclosed
US-12443129-B2 Image forming apparatus with simplified developer replenishment structure and that is user-friendly CANON KABUSHIKI KAISHA (JP) 2025-10-14 US disclosed
US-12411428-B2 Toner pack CANON KABUSHIKI KAISHA (JP) 2025-09-09 US disclosed
US-9529289-B2 Method for producing toner particles CANON KABUSHIKI KAISHA (JP) 2016-12-27 US disclosed
US-20160349649-A1 TONER AND METHOD FOR PRODUCING THE SAME CANON KABUSHIKI KAISHA (JP) 2016-12-01 US disclosed
US-20160327882-A1 TONER AND METHOD FOR PRODUCING TONER CANON KABUSHIKI KAISHA (JP) 2016-11-10 US disclosed
US-20150378275-A1 METHOD FOR PRODUCING TONER PARTICLES CANON KABUSHIKI KAISHA (JP) 2015-12-31 US disclosed
US-20150378274-A1 TONER CANON KABUSHIKI KAISHA (JP) 2015-12-31 US disclosed
EP-2860585-A1 Toner Canon Kabushiki Kaisha (JP) 2015-04-15 EP disclosed
EP-2860584-A1 Toner Canon Kabushiki Kaisha (JP) 2015-04-15 EP disclosed
US-20150099220-A1 TONER CANON KABUSHIKI KAISHA (JP) 2015-04-09 US disclosed
US-20150099222-A1 TONER CANON KABUSHIKI KAISHA (JP) 2015-04-09 US disclosed
US-20150099224-A1 TONER CANON KABUSHIKI KAISHA (JP) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118791-A1 TONER MSR1, H1-2, TAAR1 TSHR 165/4885CHRM2 23/4885CHRM4 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.